What medication can be given to control palpitations?

Medication for Controlling Palpitations

Beta-blockers or nondihydropyridine calcium channel blockers (diltiazem or verapamil) are the first-line medications to control palpitations, particularly when caused by atrial fibrillation or other supraventricular tachycardias. 1, 2

First-Line Rate Control Agents

Beta-Blockers (Preferred Initial Therapy)

• Metoprolol: 2.5-5 mg IV bolus over 2 minutes (up to 3 doses acutely); oral maintenance 25-100 mg twice daily 3, 4, 2
• Esmolol: 0.5 mg/kg IV over 1 minute loading dose, followed by 0.05-0.2 mg/kg/min infusion (useful for short-acting control) 3, 4
• Propranolol: 0.15 mg/kg IV or 0.5-1 mg over 1 minute; oral dosing 80-240 mg daily in divided doses 3, 4
• Atenolol: 5 mg IV over 5 minutes, repeat in 10 minutes if needed 3

Beta-blockers are recommended as Class I evidence for rate control in atrial fibrillation and most supraventricular tachycardias without heart failure or hypotension 1, 2, 1

Nondihydropyridine Calcium Channel Blockers

• Diltiazem: 15-20 mg (0.25 mg/kg) IV over 2 minutes; additional 20-25 mg (0.35 mg/kg) in 15 minutes if needed; maintenance infusion 5-15 mg/hour 3, 4
• Verapamil: 2.5-5 mg IV over 2 minutes, may repeat 5-10 mg every 15-30 minutes up to 20-30 mg total; oral maintenance 120-360 mg daily 3, 4

These agents are equally effective as beta-blockers for acute rate control and are Class I recommendations 1, 2

Clinical Decision Algorithm

Step 1: Assess Hemodynamic Stability

• If unstable (hypotension, ongoing ischemia, heart failure): Proceed to electrical cardioversion, not pharmacologic rate control 3, 2
• If stable: Proceed with pharmacologic rate control 3, 2

Step 2: Assess Cardiac Function

• Normal left ventricular function (LVEF >40%): Use beta-blockers OR calcium channel blockers as first-line 2, 5
• Reduced left ventricular function (LVEF ≤40%) or heart failure: Use beta-blockers OR digoxin; avoid calcium channel blockers 1, 2
• Decompensated heart failure: Use IV digoxin or IV amiodarone; do NOT use calcium channel blockers (Class III harm) 1, 2

Step 3: Check for Contraindications

• Asthma/COPD: Avoid beta-blockers; use diltiazem or verapamil instead 3, 2
• Pre-excitation syndrome (WPW): Do NOT use digoxin, calcium channel blockers, or amiodarone (may accelerate ventricular response); use procainamide or ibutilide instead 1, 3, 1, 2
• Hypotension: Exercise caution with all rate-control agents 1

Second-Line and Adjunctive Agents

Digoxin

• Loading: 0.25 mg IV every 2 hours up to 1.5 mg total 4
• Maintenance: 0.125-0.375 mg daily orally 4
• Indications: Heart failure, left ventricular dysfunction, or sedentary patients 1
• Limitations: Effective only at rest, not during exercise; should NOT be used as sole agent for paroxysmal AF (Class III) 1
• Combination therapy: Reasonable to combine with beta-blocker or calcium channel blocker for better rate control at rest and exercise (Class IIa) 1, 2

Amiodarone

• IV dosing: Can be used when other measures fail or are contraindicated (Class IIa) 1
• Oral dosing: 800 mg daily for 1 week loading, then 200 mg daily maintenance 4
• Use: Reserved for refractory cases when beta-blockers, calcium channel blockers, and digoxin fail (Class IIb) 1
• Caution: Higher toxicity profile (pulmonary, thyroid, hepatic, ocular) limits first-line use 4

Target Heart Rate

• Lenient control: Resting heart rate <110 bpm is reasonable for most patients (Class IIa) 2, 5
• Strict control: Resting heart rate 60-80 bpm and 90-115 bpm during moderate exercise if symptoms persist with lenient control 4, 5
• Assess rate control during exercise in symptomatic patients and adjust therapy accordingly (Class I) 1

Critical Pitfalls to Avoid

1. Never use calcium channel blockers in decompensated heart failure - may cause hemodynamic collapse (Class III harm) 1, 2
2. Never use digoxin, calcium channel blockers, or IV amiodarone in pre-excited AF (WPW) - may paradoxically accelerate ventricular response and cause ventricular fibrillation (Class III harm) 1, 3, 1, 2
3. Do not use digoxin alone in active patients - ineffective during exercise 1, 6
4. Avoid combining long-acting AV nodal blockers (e.g., verapamil after metoprolol) - risk of profound bradycardia 3
5. Do not use dronedarone for rate control in permanent AF - increases risk of stroke, MI, and cardiovascular death (Class III harm) 2

When Medications Fail

• AV nodal ablation with permanent pacemaker is reasonable when pharmacologic therapy is insufficient or causes intolerable side effects (Class IIa) 1, 2
• Should not be performed without prior medication trial (Class III) 1, 2